TrialArthritis research & therapy2025

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study.

Filip Van den Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.